{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:01:46Z","timestamp":1794045706097,"version":"4.8.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"am","delay-in-days":182,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jcrc.2023.154330","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T14:00:08Z","timestamp":1685541608000},"page":"154330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients presenting sepsis-induced immunosuppression: The GRID randomized controlled trial"],"prefix":"10.1016","volume":"78","author":[{"given":"Charles-Herv\u00e9","family":"Vacheron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Lepape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Venet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Monneret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Gueyffier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Boutitie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Vallin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Schwebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Maucort-Boulch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Friggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcrc.2023.154330_bb0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ccc.2017.08.007","article-title":"Management of Sepsis-Induced Immunosuppression","volume":"34","author":"Venet","year":"2018","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.jcrc.2023.154330_bb0010","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00134-010-1962-x","article-title":"Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock","volume":"36","author":"Landelle","year":"2010","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2023.154330_bb0015","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00134-006-0204-8","article-title":"Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock","volume":"32","author":"Monneret","year":"2006","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2023.154330_bb0020","first-page":"2746","article-title":"Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction","volume":"37","author":"Lukaszewicz","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2023.154330_bb0025","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00134-003-1826-8","article-title":"HLA-DR as a marker for increased risk for systemic inflammation and septic complications after cardiac surgery","volume":"29","author":"Oczenski","year":"2003","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2023.154330_bb0030","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002044","article-title":"A review of GM-CSF therapy in Sepsis","volume":"94","author":"Mathias","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jcrc.2023.154330_bb0035","article-title":"Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): a structured summary of a study protocol for a randomised controlled trial","volume":"21","author":"Bosteels","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.jcrc.2023.154330_bb0040","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/thoraxjnl-2017-211323","article-title":"Randomised controlled trial of GM-CSF in critically ill patients with impaired neutrophil phagocytosis","volume":"73","author":"Pinder","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.jcrc.2023.154330_bb0045","doi-asserted-by":"crossref","first-page":"126","DOI":"10.7150\/ijms.1.126","article-title":"HLA-DR regulation and the influence of GM-CSF on transcription, surface expression and shedding","volume":"1","author":"Perry","year":"2004","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.jcrc.2023.154330_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144003","article-title":"Influence of granulocyte-macrophage Colony-stimulating factor or influenza vaccination on HLA-DR, infection and delirium days in immunosuppressed surgical patients: double blind, randomised controlled trial","volume":"10","author":"Spies","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.jcrc.2023.154330_bb0055","doi-asserted-by":"crossref","first-page":"R58","DOI":"10.1186\/cc10031","article-title":"Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis","volume":"15","author":"Bo","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2023.154330_bb0060","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1164\/rccm.200903-0363OC","article-title":"Granulocyte\u2013macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression","volume":"180","author":"Meisel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcrc.2023.154330_bb0065","first-page":"150","article-title":"Molgramostim (GM-CSF) associated with antibiotic treatment in nontraumatic abdominal sepsis: a randomized, double-blind, placebo-controlled clinical trial","volume":"141","author":"Orozco","year":"2006","journal-title":"Arch Surg Chic Ill 1960"},{"key":"10.1016\/j.jcrc.2023.154330_bb0070","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1378\/chest.127.6.2139","article-title":"Effect of granulocyte-monocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in nonneutropenic patients","volume":"127","author":"Rosenbloom","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jcrc.2023.154330_bb0075","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-physiol-061121-040214","article-title":"Sepsis-induced immunosuppression","volume":"84","author":"Torres","year":"2022","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.jcrc.2023.154330_bb0080","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for Sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2023.154330_bb0085","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS international Sepsis definitions conference","volume":"31","author":"Levy","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2023.154330_bb0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/cyto.b.21043","article-title":"Inter-laboratory assessment of flow cytometric monocyte HLA-DR expression in clinical samples","volume":"84","author":"Demaret","year":"2013","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.jcrc.2023.154330_bb0095","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/cyto.b.21987","article-title":"A flow cytometric assay for HLA-DR expression on monocytes validated as a biomarker for enrollment in sepsis clinical trials","volume":"100","author":"Quadrini","year":"2021","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.jcrc.2023.154330_bb0105","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/CCM.0000000000005270","article-title":"Immune profiling demonstrates a common immune signature of delayed acquired immunodeficiency in patients with various etiologies of severe injury","volume":"50","author":"Venet","year":"2022","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2023.154330_bb0110","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S1473-3099(13)70001-X","article-title":"Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jcrc.2023.154330_bb0115","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/imr.12499","article-title":"The immune system\u2019s role in sepsis progression, resolution, and long-term outcome","volume":"274","author":"Delano","year":"2016","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jcrc.2023.154330_bb0120","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13613-017-0304-3","article-title":"Assessment of sepsis-induced immunosuppression at ICU discharge and 6 months after ICU discharge","volume":"7","author":"Zorio","year":"2017","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.jcrc.2023.154330_bb0125","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.coi.2013.05.006","article-title":"Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies","volume":"25","author":"Venet","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jcrc.2023.154330_bb0130","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s00134-019-05704-z","article-title":"Immune checkpoint inhibition in sepsis: a phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab","volume":"45","author":"Hotchkiss","year":"2019","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2023.154330_bb0135","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nm0697-678","article-title":"Monocyte deactivation in septic patients: restoration by IFN-gamma treatment","volume":"3","author":"D\u00f6cke","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.jcrc.2023.154330_bb0140","doi-asserted-by":"crossref","first-page":"98960","DOI":"10.1172\/jci.insight.98960","article-title":"Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial","volume":"3","author":"Francois","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jcrc.2023.154330_bb0145","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/jcm11010096","article-title":"Concomitant assessment of monocyte HLA-DR expression and ex vivo TNF-\u03b1 release as markers of adverse outcome after various injuries\u2014insights from the REALISM study","volume":"11","author":"Bidar","year":"2021","journal-title":"J Clin Med"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944123000795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944123000795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:50:26Z","timestamp":1760125826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944123000795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":28,"alternative-id":["S0883944123000795"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2023.154330","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients presenting sepsis-induced immunosuppression: The GRID randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2023.154330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154330"}}